bionlp-st-gro-2013-development Home  

PubMed:9311921 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-5 TranscriptionFactor denotes NF-AT
E1 6-16 PositiveRegulation denotes activation
E2 17-24 Increase denotes induced
T5 30-53 Protein denotes CAML-interacting member
T4 61-91 Protein denotes tumor necrosis factor receptor
E4 105-115 PositiveRegulation denotes Activation
T6 123-179 TranscriptionFactor denotes nuclear factor of activated T cells transcription factor
T13 181-186 TranscriptionFactor denotes NF-AT
T14 214-224 Cell denotes lymphocyte
T15 237-241 Protein denotes CAML
T16 243-283 Protein denotes calcium-modulator and cyclophilin ligand
T18 311-316 Protein denotes NF-AT
E6 317-327 PositiveRegulation denotes activation
E7 333-346 PositiveRegulationOfGeneExpression denotes overexpressed
T21 350-364 Cell denotes Jurkat T cells
T7 382-412 Protein denotes tumor necrosis factor receptor
T24 468-472 Protein denotes CAML
T9 496-523 Protein denotes lymphocyte-specific protein
T27 536-540 Protein denotes TACI
T28 542-585 Protein denotes transmembrane activator and CAML-interactor
T29 595-602 CellComponent denotes surface
T30 618-630 Cell denotes Jurkat cells
T31 636-640 Protein denotes TACI
T32 650-660 Protein denotes antibodies
E8 668-678 PositiveRegulation denotes activation
E3 668-678 PositiveRegulation denotes activation
E5 668-678 PositiveRegulation denotes activation
T34 686-707 TranscriptionFactor denotes transcription factors
T35 708-713 TranscriptionFactor denotes NF-AT
T36 715-719 TranscriptionFactor denotes AP-1
T37 725-733 TranscriptionFactor denotes NFkappaB
T38 735-739 Protein denotes TACI
E9 748-758 PositiveRegulation denotes activation
T40 762-767 Protein denotes NF-AT
E10 785-792 NegativeRegulation denotes blocked
T10 816-827 MutantProtein denotes CAML mutant
T44 846-850 Protein denotes CAML
E11 856-865 SignalingPathway denotes signaling
R1 E4 T14 locatedIn Activation,lymphocyte
R10 T18 E6 hasPatient NF-AT,activation
R11 T15 E7 hasPatient CAML,overexpressed
R12 T35 E8 hasPatient NF-AT,activation
R13 T38 E9 hasAgent TACI,activation
R14 T40 E9 hasPatient NF-AT,activation
R15 T10 E10 hasAgent CAML mutant,blocked
R16 E9 E10 hasPatient activation,blocked
R17 T36 E3 hasPatient AP-1,activation
R18 T37 E5 hasPatient NFkappaB,activation
R2 E7 T21 locatedIn overexpressed,Jurkat T cells
R3 T29 T30 locatedIn surface,Jurkat cells
R5 T1 E1 hasPatient NF-AT,activation
R6 T5 E2 hasAgent CAML-interacting member,induced
R7 E1 E2 hasPatient activation,induced
R8 T13 E4 hasPatient NF-AT,Activation
R9 T15 E6 hasAgent CAML,activation